Efficacy of Ascorbic Acid in Reduction of Stroke Complications in a Permanent Model of Middle Cerebral Artery Occlusion in Male Rats
- سال انتشار: 1394
- محل انتشار: مجله دانشگاه علوم پزشکی کرمان، دوره: 22، شماره: 5
- کد COI اختصاصی: JR_JKMU-22-5_001
- زبان مقاله: انگلیسی
- تعداد مشاهده: 117
نویسندگان
Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Ph.D. Student, Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Associate Professor, Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Ph.D. Student, Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Ph.D. Student, Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Ph.D. Student, Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
M.Sc. Student, Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
M.Sc. Student, Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Associate Professor, Department of Physiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
چکیده
Background & Aims: Stroke is the third leading cause of death. Oxidative stress has a principal role in the complications of stroke. Due to this fact and the antioxidant effects of ascorbic acid, this study was designed to evaluate the effect of ascorbic acid on reduction of stroke complications in a permanent model of middle cerebral artery (MCA) occlusion in male rats. Methods: In this experimental study, the rats were divided into ۳ groups of control, ascorbic acid, and surgicalsham. Stroke wasinduced by cauterization of MCA. The animals' brain wassliced and stained using tetrazolium chloride (TTC) ۴۸ hours after stroke induction. Then, infarction volume was determined using image processing software. In addition, behavioral tests, such as neurologic deficits, were evaluated ۲۴ and ۴۸ hours afterstroke induction. Data were statistically analyzed using One-way ANOVA test. Results: The infarct volume significantly reduced in the ascorbic acid treated group in comparison with control group (P < ۰.۰۱۰). Moreover, blood-brain barrier (BBB) breakdown, brain edema volume (P < ۰.۰۰۱), and the level of matrix metallopeptidase-۹ (MMP-۹) (P < ۰.۰۵۰) significantly reduced following treatment by ascorbic acid. Neurologic deficits, which were assessed using the Bederson Grading System, showed relative improvement in the ascorbic acid treated group (P < ۰.۰۵۰). Conclusion:Thisstudy showed that ascorbic acid, due to its neuroprotective effects, can significantly reduce the complications ofstroke.کلیدواژه ها
Ascorbic acid, Neuroprotection, Strokeاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.